THE TIME IS NOW FOR EUROPEAN HTA: HOW WILL THE EVOLUTION OF EUROPEAN HTA IMPACT ACCESS TO INNOVATIVE MEDICINES?

被引：0
|
作者：
Laisne, E. [1 ]
Allen, N. [1 ]
Kolotourou, K. [1 ]
Sattler-Ermacora, P. [1 ]
Grosvenor, A. [1 ]
机构：
[1] Precis Xtract, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP301
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [21] TIME TO HTA DECISION FOR INTERNATIONALISED MEDICINES IN AUSTRALIA, CANADA AND EUROPE
    Cai, J.
    McAuslane, N.
    Liberti, L.
    VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [22] Actual patient access to innovative medicines in six European countries
    Vancoppenolle, J.
    Franzen, N.
    Koole, S.
    Retel, V.
    van Harten, W.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1146 - S1147
  • [23] The challenges of access to innovative medicines with limited evidence in the European Union
    Vallano, Antonio
    Pontes, Caridad
    Agusti, Antonia
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] HTA EDUCATIONAL NEEDS IN CENTRAL-EASTERN-SOUTH EUROPEAN (CESE) COUNTIRES - RESULTS OF JOC HTA PROJECT
    Hermanowski, T. R.
    Zawada, A.
    VALUE IN HEALTH, 2018, 21 : S182 - S182
  • [25] Towards a regulation of HTA in Europe: the proposal from the European Commission
    Migliore, Antonio
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (01) : 1 - 2
  • [26] HTA PRINCIPLES INCLUSION IN NEW EUROPEAN UNION MEMBER STATES
    Tomek, D.
    Visnansky, M.
    Marusakova, E.
    VALUE IN HEALTH, 2012, 15 (07) : A319 - A319
  • [27] EUROPEAN HTA, PRICING AND REIMBURSEMENT ROAD MAPS: REVISITED 2016
    Mason, N.
    Schurer, M.
    VALUE IN HEALTH, 2016, 19 (03) : A288 - A288
  • [28] INVESTIGATING EUROPEAN HTA AND PRICING FOR HISTOLOGY-AGNOSTIC TREATMENTS
    Boehmer, C.
    Sherwin, G.
    Gomiero, C.
    Bruni, Severi D.
    VALUE IN HEALTH, 2019, 22 : S503 - S503
  • [29] The development of HTA collaboration at European level and the challenge of the EU regulation
    Ruether, A.
    Petelos, E.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [30] EARLY HTA ADVICE IN EUROPEAN COUNTRIES: SCOPE AND ASSOCIATED COSTS
    Palkmets, O.
    Nagda, N.
    Sear, R.
    VALUE IN HEALTH, 2017, 20 (09) : A695 - A695
12345